Malaysian Journal of Public Health Medicine

Total Page:16

File Type:pdf, Size:1020Kb

Malaysian Journal of Public Health Medicine 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- MALAYSIAN JOURNAL OF PUBLIC HEALTH MEDICINE ISSN: 1675-0306 Volume 16 (Supplement 3) 2016 Official Publication of the MALAYSIAN PUBLIC HEALTH PHYSICIANS’ ASSOCIATION 1 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- MJPHM Official Journal of Malaysian Public Health Specialist Association EDITORIAL BOARD Chief Editor Prof. Dato’ Dr. Syed Mohamed Aljunid International Centre for Casemix and Clinical Coding, Faculty of Medicine, Universiti Kebangsaan Malaysia Deputy Chief Editor Prof. Dr. Sharifa Ezat Wan Puteh Faculty of Medicine, Universiti Kebangsaan Malaysia Dato’ Dr. Lokman Hakim Sulaiman Ministry of Health Malaysia Assoc. Prof. Dr Retneswari Masilamani University Malaya Assoc Prof. Dr. Mohamed Rusli Abdullah University Sains Malaysia Assoc. Prof. Saperi Sulong University Kebangsaan Malaysia Prof. Dr. Maznah Dahlui University Malaya Dr. Roslan Johari Ministry of Health Malaysia Dr. Othman Warijo Ministry of Health Malaysia Dr. Amin Sah bin Ahmad Ministry of Health Malaysia Dr. Ghazali bin Chik Ministry of Health Malaysia Dr. Sabrina binti Che Abd Rahman Ministry of Health Malaysia Dr. Mariam binti Mohamad Universiti Teknologi MARA (UiTM) Dr. Amrizal Muhd Nur National University of Malaysia Chief Editor Malaysian Journal of Public Health Medicine (MJPHM) International Centre for Casemix and Clinical Coding Universiti Kebangsaan Malaysia Medical Centre (UKMMC) Jalan Yaacob Latif, 56000 Cheras, Kuala Lumpur Malaysia ISSN: The Malaysian Journal of Public Health Medicine is published thrice a year Copyright reserved @2001 Malaysian Public Health Physicians’ Association Secretariat Address: International Centre for Casemix and Clinical Coding, Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Jalan Yaacob Latif, 56000 Cheras, Kuala Lumpur Malaysia Tel: 03-91456986/6987/6988 Fax: 03-91456685, Email: [email protected] 2 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- MJPHM Official Journal of Malaysian Public Health Specialist Association 2nd PHARMACOECONOMICS ANDOUTCOME RESEARCH CONFERENCE 2014 7- 9th March 2014 THE ROYALE CHULAN, KUALA LUMPUR, MALAYSIA Organized by Malaysian Society for Pharmacoeconomics and Outcome Research In collaboration with United Nations University International Institute for Global Health; Pharmaceutical Services Division, Ministry of Health; supported by AbbVie; Azmi Burhani Consulting and Servier. EDITORIAL BOARD CONFERENCE ADVISOR : PROF. DATO’ DR. SYED MOHAMED ALJUNID CHAIRPERSON : DR. SORAYA AZMI SECRETARIES : LEE SIT WAI AND NURUL AZWANI NADIA MANSOR MEMBERS: ZAITON KAMARRUDDIN NOORMAH DARUS PROF. DR. SHARIFA EZAT WAN PUTEH KATHLEEN YEOH AZUANA RAMLI PROF. DR. SAMSINAH HJ HUSSAIN DR. RAMLI ZAINAL DR. ZAFAR AHMED 3 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 The 2nd Pharmacoeconomics and Outcome Research Conference 2014 was jointly organized by the Malaysian Society for Pharmacoeconomics and Outcome Research (MYSPOR), United Nations University International Institute for Global Health and Pharmaceutical Services Division, Ministry of Health, Malaysia. Objectives of this event are as follow: To discuss current and future developments related to pharmacoeconomics and health policy decision- making in Malaysia To provide a platform for researchers, healthcare practitioners and decision-makers who usepharmacoeconomics and outcomes research to shareknowledge and experience To provide an opportunity for researchers and students to showcase their research through poster and podium sessions Conference format The 2nd Pharmacoeconomic and Outcome Research Conference 2014 was held from the 7th to 9th March 2014 at The Royale Chulan, Kuala Lumpur, Malaysia.The Conference theme was “Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage”. This Conference wasofficiated by the Deputy Director-General (Medical), Ministry of Health, Malaysia, Y.B. Datuk Dr Jeyaindran Tan Sri Sinnaduraiwho also delivered the keynote address. Six panel sessionswere presented by invited speakers. In addition, two symposium sessions, one educational workshopand scientific paper presentations (oral and poster) were carried out. The conference included participants who are professionals from the MalaysianMinistry of Health, industry and academia as well as students working in the area or interested in Pharmacoeconomics, health economics and outcomes research. 4 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- CONTENTS PAGE PANEL 1: PHARMACOECONOMICS IN DECISION-MAKING – SHARING REGIONAL EXPERIENCES 14 PHARMACOECONOMICS IN DECISION-MAKING: SHARING EXPERIENCE FROM AUSTRALIA Shu Chuen Li HEALTH ECONOMICS IN DECISION-MAKING – SHARING THAILAND EXPERIENCE Chaiyakunapruk PHARMACOECONOMICS IN DECISION-MAKING – SHARING TAIWAN EXPERIENCE Jasmine Raoh-Fang Pwu PANEL 2: PHARMACOECONOMICS IN HEALTHCARE TRANSFORMATION 15 THE FUTURE OF HEALTH INFORMATION SYSTEM – POTENTIAL USE FOR OBSERVATIONAL RESEARCH Md Khadzir Bin Sheikh Hj Ahmad HTA IN MALAYSIA: MOVING FORWARD Noormah Mohd Darus PANEL 3 : BRIDGING SCIENCE TO POLICY WITH PHARMACOECONOMICS 16 INTRODUCTION TO THE THE COST-EFFECTIVENESS THRESHOLD Sharifa Ezat Wan Puteh DO WE NEED A THRESHOLD IN MALAYSIA? Asrul Akmal Shafie VALUE-BASED PRICING Kenneth KC Lee MULTI-CRITERIA DECISION ANALYSIS (MCDA) AND OTHER NEW IDEAS Soraya Azmi PANEL 4: COST-EFFECTIVENESS vs. COST-REDUCTION: THE BALANCE BETWEEN 18 ACCESSIBILITY, AFFORDABILITY AND AVAILABILITY COST-EFFECTIVENESS VS. COST REDUCTION: AN AUSTRALIAN CASE STUDY Shu Chuen Li COST-EFFECTIVENESS OF TREATING TO TARGETS WITH BIOLOGICS IN IMIDS Carol Bao THE CHALLENGE FOR PUBLIC HEALTH: PROVIDING UNIVERSAL COVERAGE AND COST- EFFECTIVE TREATMENT Feisul Idzwan Mustapha PANEL 5: PHARMACOECONOMICS RESEARCH – ARE WE READY FOR IT? 19 WHAT ARE THE COMPONENTS NEEDED TO CONDUCT PHARMACOECONOMICS RESEARCH? Adrian Goh DATA AVAILABILITY FOR PHARMACOECONOMICS RESEARCH Syed Mohamed Aljunid 5 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- HOW TAIWAN BUILT CAPACITY TO CONDUCT HTA ASSESSMENTS Jasmine Raoh-Fang Pwu THE RELEVANCE OF HEALTH ECONOMICS AND OUTCOMES IN CLINICAL PRACTICE Sunita Bavanandan PANEL 6: PHARMACOECONOMICS AND HEALTHCARE TRANSFORMATION–COLLABORATIONS 21 FOR THE FUTURE INDUSTRYS ROLE - JOINING TOGETHER TO STRENGTHEN PHARMACOECONOMICS RESEARCH IN MALAYSIA Yew Wei Tarng LUNCH SYMPOSIUM 22 HEALTH TECHNOLOGY APPROACHES AND FIT FOR PURPOSE IN DEVELOPING HEALTH CARE SYSTEMS Christoph Glaetzer 6 2nd PHARMACOECONOMICS AND OUTCOME RESEARCH CONFERENCE 2014 Pharmacoeconomics in Healthcare Transformation: Towards Universal Coverage 7- 9th March 2014 ------------------------------------------------------------------------------------------------------------------------------- SCIENTIFIC ABSTRACTS PAGE A01 23 THE INCIDENCE OF ADVERSE EFFECTS DUE TO FLUOROURACIL, EPIRUBICIN AND CYCLOPHOSPHAMIDE (FEC) CHEMOTHERAPY IN BREAST CANCER PATIENTS AT HOSPITAL TENGKU AMPUAN RAHIMAH (HTAR), KLANG Norima MN, Mazni MTN, Yeow WJ, Chong YT, Yeoh JJJ 24 A02 GLYCAEMIC CONTROL OF DIABETIC PATIENTS IN PHARMACIST-MANAGED TELEPHONIC INSULIN TITRATION Ramelan A, Lin SN, Woon SM, Mohd Noh FA, Wong KM, Ibrahim NF 25 A03 PRIMARY CARE SETTING IN KLANG: ARE ANTIBIOTICS USAGE JUSTIFIED? Cheang CYM, Norharlina S, Gan KZ A04 26 A STUDY OF CEPHALOSPORIN USE IN FEMALE MEDICAL WARD IN HOSPITAL BANTING Te CY, Azwa A, Norhamiza H, Nurul Izzaty A A05 27 BRING BACK MEDICATION: A STUDY OF PATIENTS’ AWARENESS, COST SAVED AND STORAGE PRACTICE IN SELAYANG HOSPITAL Khoo HF, Ang YJ, Lim XY, Cheok KY, Sabastian SS, Lim CH, Geh SW, Leong SL A06 28 ASSESSMENT OF HEALTHCARE PROFESSIONALS’ KNOWLEDGE ON INTERACTIONS OF WARFARIN WITH DRUGS, SUPPLEMENTS AND NUTRIENTS IN HOSPITAL AMPANG, MALAYSIA. Lo SH, Md Shukor NZA, Md Yunus YA, Kong SS, Foo WF, Lee WLW, Lim YS A07 29 CLINICAL IMPACT OF EMPIRICAL ANTIFUNGAL THERAPY ON THE SURVIVAL FROM INFECTION IN CHEMOTHERAPY-INDUCED FEBRILE NEUTROPAENIC ADULT PATIENTS Chong SC, Thomas PT, Birinder K 30 A08 COAGULATION FACTOR CONCENTRATES USAGE IN MALAYSIA 2012 Nursabrina AA, Gan CB, Nasreen N, Heng SC, Lim YS A09 31 UNAUTHORIZED PRESCRIPTION IN OUTPATIENT PHARMACY HOSPITAL AMPANG
Recommended publications
  • 1. MOA AAA 2016 Abstract
    Abstract Combined Meeting of the th Malaysian Orthopaedic 46Association Annual General Meeting / Annual Scientific Meeting th ASEAN Arthroplasty 10 Association Meeting 2016 Fundamentals In Orthopaedics – Back To Basics Pre-Conference Day Conference Days 25th May 2016 26th to 28th May 2016 Persada Johor International Convention Centre, Johor Bahru, Malaysia. www.moa-home.com Abstract CD (Please click on the links below to view the respective categories of abstracts.) Oral Presentations Abstracts Poster Presentations Abstracts (Click Here...) Combined Meeting of the 46th Malaysian Orthopaedic Association Annual General Meeting / Annual Scientific Meeting & 10th ASEAN Arthroplasty Association Meeting 2016 26th May 2016 (Thursday) - Lecture Hall MOA 1, Level 3 TIME TOPIC SPEAKER 0700 -1730 REGISTRATION COUNTER OPENS SUBIR SENGUPTA MEMORIAL LECTURE Chairperson Prof Dr Saw Aik 0830 - 0900 Prevention And Early Detection Of DDH - The Japanese SM 01 Prof Dr Makoto Kamegaya Experience OPENING CEREMONY 0900 - 1030 Orthopaedics At The Frontlines In A Changing Globalised World. SK 01 Roles And Responsibilities. Dato' Dr Ahmad Faizal Mohd Perdaus A View From A Humanitarian And Colleauge. 1030 - 1100 TEA BREAK & EXHIBIT VISIT SPORTS Dr Shamsul Iskandar Hussein Chairperson Dr Raymond Yeak Dieu Kiat Revision Anterior Cruciate Ligament Reconstruction: Analysis 1100 - 1112 SX 01 Of Causes Of Failures, Preoperative Clinical Evaluation And Dr Deepak V. Patel Planning, Surgical Technique, And Clinical Outcomes SLAP (Superior Labrum Anterior Posterior)
    [Show full text]
  • Nursing Division Ministry of Health Malaysia
    NURSING DIVISION MINISTRY OF HEALTH MALAYSIA First Edition Mei 2017 SAFE OPERATING PROSEDURE FOR ADMINISTRATION OF INTRAVENOUS ( BOLUS ) EDICATION SAFE OPERATING PROSEDURE FOR ADMINISTRATION OF INTRAVENOUS ( BOLUS ) EDICATION ACKNOWLEDGEMENT Nursing Division Ministry of Health Malaysia gratefully acknowledges the expert contributions made by the following members, without whom the development of this consensus document would not be possible. ADVISOR Puan Hajah Rosena binti Abdul Ghani Director of Nursing Division, MOH EDITIORS Dr. Nor’Aishah Binti Abu Bakar Head of Patient Safety Unit Senior Public Health Physician & Senior Principle Assistant Director Medical Care Quality Section Medical Development Division, Ministry of Health Malaysia Puan Monica Chee Soon Nyuk Senior Assistant Director of Nursing, Nursing Division, MOH Puan Ng Siew Luan Nursing Matron, Nursing Division, MOH TECHNICAL WORKING GROUP Puan Darmawan binti Ramli Nursing Tutor, Unit Curriculum, Nursing Division, MOH Puan Suzana binti Jaafar Assistant Director, Nursing Division. MOH Puan Norlaila binti Mohd Husin Assistant Director, Nursing Division. MOH Puan Zanita binti Ahmad Clinical Nursing Matron, Family Health Development Division, MOH Puan Razmiyah binti Awang Nursing Matron, Nursing Division, MOH Puan See Booi Cheng Nursing Matron, Family Health Development Division, MOH Puan Noor Wati binti Esa Nursing Matron, Kuala Lumpur General Hospital Puan Mariati binti Alias Nursing Matron, Putrajaya Hospital Puan Noorsiah binti Harun Nursing Matron, Kajang Hospital Puan Zalimah
    [Show full text]
  • Risk Factors Associated with Necrotising Enterocolitis in Very Low Birth Weight Infants in Malaysian Neonatal Intensive Care Units
    O riginal A rticle Singapore Med J 2012; 53(12) : 826 Risk factors associated with necrotising enterocolitis in very low birth weight infants in Malaysian neonatal intensive care units Nem-Yun Boo1, MRCP, FRCPCH, Irene Guat Sim Cheah2, MRCP, FRCPCH; Malaysian National Neonatal Registry Introduction This study aimed to identify the risk factors associated with necrotising enterocolitis (NEC) in very low birth weight (VLBW; weight < 1,501 g) infants in Malaysian neonatal intensive care units (NICUs). Methods This was a retrospective study based on data collected in a standardised format for all VLBW infants born in 2007 (n = 3,601) and admitted to 31 NICUs in Malaysian public hospitals. A diagnosis of NEC was made based on clinical, radiological and/or histopathological evidence of stage II or III, according to Bell’s criteria. Logistic regression analysis was performed to determine the significant risk factors associated with NEC. ResuLts 222 (6.2%) infants developed NEC (stage II, n = 197; stage III, n = 25). 69 (31.3%) infants died (stage II, n = 58; stage III, n = 11). The significant risk factors associated with NEC were: maternal age (adjusted odds ratio [OR] 1.024, 95% confidence interval [CI] 1.003–1.046; p = 0.027), intrapartum antibiotics (OR 0.639, 95% CI 0.421–0.971; p = 0.036), birth weight (OR 0.999, 95% CI 0.998–0.999; p < 0.001), surfactant therapy (OR 1.590, 95% CI 1.170– 2.161; p = 0.003), congenital pneumonia (OR 2.00, 95% CI 1.405–2.848; p < 0.001) and indomethacin therapy for the closure of patent ductus arteriosus (PDA) (OR 1.821, 95% CI 1.349–2.431; p = 0.001).
    [Show full text]
  • Curriculum Vitae BIODATA Name Zaiton Kamarruddin P.C.M IC 630624-08-5388 Age 58
    Curriculum Vitae BIODATA Name Zaiton Kamarruddin P.C.M IC 630624-08-5388 Age 58 Nationalilty Malaysian State Health Deputy Director (Pharmacy) Current State Health Department Position Perak Darul Ridzuan c/o Hospital Bahagia Ulu Kinta 31250 Tanjung Rambutan Address Perak Darul Ridzuan. Email [email protected] Contact Off : 605-5337318 ACADEMIC ACHIEVEMENTS PhD Program ( Health Sciences)( 2001-2005) 2001-2005 CURTIN University of Technology, Perth, WA M.Pharm (Clinical Pharmacy) – University of Science Malaysia (USM). 1994 Penang (1994) 1987 B. Pharm (Hons)- University of Science Malaysia (USM). Penang (1987) WORK ACHIEVEMENTS / AWARD 2013 Excellent Service Award, Public Service MOH 2012, by JKN Selangor 2012 Excellent Service Certificate, December 2012, Hospital Kajang. 2001 Excellent Service Award, Public Service 2012, by JKN Perak Awarded by the Competency Unit, Ministry of Health, Malaysia for Excellent Efficiency. (PTK 4) 2020 Anugerah Darjah Kebesaran, Bintang Dan Pingat Negeri Perak Tahun 2020 - `PADUKA CURA SI MANJA KINI ` (P.C.M) Page 1 of 12 WORK EXPERIENCES Head of Unit (LEAN), 2019 -2020 Centre for Organizational Excellence Development Institute for Health Management, Ministry of Health Malaysia (MOH) Core Business: Research, Training and Consultancy related to LEAN Healthcare / Management 2014-2018 Head of Division, Healthcare Quality Research Division,Institute for Health Systems Research (IHSR),Ministry of Health Malaysia. Project Leader in Lean Healthcare Initiatives of MOH under Government Transformation Program (GTP)
    [Show full text]
  • ABSTRACT BOOK CONTENT Pages 1
    International Medical University 26 October 2017 The undergraduate health professional students are increasingly expected to undertake research project. There is currently inadequate opportunity for students to gain a good understanding of the research process and present their research output. This conference will serve as a good avenue for students to achieve that as well as for networking and future collaboration. ABSTRACT BOOK CONTENT Pages 1. Organizing & Scientific Committees 1 2. Welcome message from Vice Chancellor 2 3. Welcome message from Dean, School of Medicine 3 4. Welcome message from Organizing and Scientific Chairpersons 4 5. Conference programme 5 6. Synopsis and speakers' information: Forum on Personalized Medicine 6 7. Synopsis and speakers' information: Plenaries 7-9 8. Judges for oral and poster presentations 10 9. Criteria for judging oral and poster presentations 11 10. List of oral presentations 12-13 11. List of poster presentations 14-16 12. Oral presentation abstracts 17-35 13. Poster presentation abstracts 36-80 Advisers: 1. Professor Dr Nazimah Idris 2. Professor Dato' Dr Sivalingam Nalliah Members of Organizing Committee: 1. Professor Dr Esha Das Gupta (Chairperson) 2. Dr Abdul Rasyid Sulaiman 3. Mohamad Syahrul Nizam bin Md Ishak 4. Inthirah Narayanan 5. Eza Norjuana bt Kamarudin Members of Scientific Committee: 1. Professor Dr Esha Das Gupta (Chairperson) 2. Professor Dr Teng Cheong Lieng (Co-Chair) 3. Professor Dr Leong Chee Onn 4. Associate Professor Dr Tan Eng Lai 5. Dr Abhishek Parolia 1 Page MESSAGE FROM THE VICE-CHANCELLOR, INTERNATIONAL MEDICAL UNIVERSITY Research has been defined as "the creation of new knowledge and/or the use of existing knowledge in a new and creative way so as to generate new concepts, methodologies and understandings." The reporting of research is often in the form of a publication in the peer reviewed journal.
    [Show full text]
  • (PPE)? • Barriers To
    Official Journal of the Academy of Family Physicians of Malaysia and Family Medicine Specialist Association 2020 Volume 15 No. 1 • How should front-line general practitioners use personal protective equipment (PPE)? • Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers PP2089/12/2012 (031677) ISSN : • Lifestyle factors associated with cardiovascular risk among 1985-207X (Print) 1985-2274 (Electronic) healthcare workers from the tertiary hospitals in Sarawak About MFP TheMalaysian Family Physician is the official journal of the Academy of Family Physicians of Malaysia. It is published three times a year. Goal: The MFP is an international journal that disseminates knowledge and clinical evidence of quality and relevance to primary care. The journal acts as the voice of family physicians, researchers and other members of the primary care team on issues that are relevant to clinical practice. Scope: The MFP publishes: i. Research – Original Articles, Reviews ii. Education – Case Reports/Clinical Practice Guidelines/Test Your Knowledge. We only encourage case reports that have the following features: 1. Novel aspects 2. Important learning points 3. Relevant to family practice iii. Invited debate/commentary/discussion/ letters/online/comment/editorial on topics relevant to primary care. iv. A Moment in the Life of a Family Physician - Besides articles covering primary care research, training, clinical practice and clinical management, we also encourage submission of a short narrative to share perspectives, voice, views and opinions about a family physician’s experience that has impacted on their practice or life. This should be a reflective piece of less than 500 words in length.
    [Show full text]
  • The Functional Outcome of Patients Following Spinal Injury in Asia Metropolitans: Does the Prehospital Spine Immobilization Matter?
    The Functional Outcome of Patients Following Spinal Injury in Asia Metropolitans: Does the Prehospital Spine Immobilization Matter? Hsuan An Chen Far Eastern Memorial Hospital Shuo Ting Hsu Far Eastern Memorial Hospital Sang Do Shin Seoul National University College of Medicine and Hospital Sabariah Faizah Jamaluddin Universiti Teknologi MARA Do Ngoc Son Bach Mai Hospital Ki Jeong Hong Seoul National University College of Medicine and Hospital Hideharu Tanaka Graduate School of Kokushikan University Jen Tang Sun Far Eastern Memorial Hospital Wen-Chu Chiang ( [email protected] ) National Taiwan University Hospital Research Article Keywords: Patients, Spinal Injury, Prehospital, Immobilization Posted Date: July 27th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-724919/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/15 Abstract Prehospital spinal immobilization is a widely used procedure in the emergency medical service (EMS) system worldwide, while the incidence of patients with spinal injury (SI) is relatively low, and unnecessary prehospital spinal immobilization is associated with patient complications. This study aimed to determine the association between prehospital spine immobilization and favorable functional outcomes at hospital discharge among trauma patients with SI. We conducted a retrospective cohort study using the Pan-Asia Trauma Outcomes Study (PATOS) registry data from January 1, 2016, to November 30, 2018. A total of 759 patients with SI were enrolled from 43,752 trauma patients in the PATOS registry during the study period. The subjects had a median age of 58 years ( Q1−Q3,41−72), and 438 (57.7%) patients had prehospital spine immobilization.
    [Show full text]
  • Surgical Site Infection After Gastrointestinal Surgery in Children: an International, Multicentre, Prospective Cohort Study
    Original research BMJ Glob Health: first published as 10.1136/bmjgh-2020-003429 on 3 December 2020. Downloaded from Surgical site infection after gastrointestinal surgery in children: an international, multicentre, prospective cohort study GlobalSurg Collaborative To cite: GlobalSurg ABSTRACT Key questions Collaborative. Surgical site Introduction Surgical site infection (SSI) is one of the infection after gastrointestinal most common healthcare- associated infections (HAIs). What is already known? surgery in children: an However, there is a lack of data available about SSI in international, multicentre, There is a lack of data describing the incidence and children worldwide, especially from low- income and ► prospective cohort risk factors for surgical site infection (SSI) in chil- middle- income countries. This study aimed to estimate the study. BMJ Global Health dren. This paucity of data is particularly prevalent incidence of SSI in children and associations between SSI 2020;5:e003429. doi:10.1136/ in low- middle income populations (LMICs), who are and morbidity across human development settings. bmjgh-2020-003429 likely to be affected most by SSI, yet no prospective, Methods A multicentre, international, prospective, multicentric comparative data exist. Handling editor Senjuti Saha validated cohort study of children aged under 16 years undergoing clean- contaminated, contaminated or dirty What are the new findings? ► Additional material is gastrointestinal surgery. Any hospital in the world providing Children undergoing gastrointestinal surgery in low- published online only. To view, ► paediatric surgery was eligible to contribute data between please visit the journal online middle development countries are significantly more (http:// dx. doi. org/ 10. 1136/ January and July 2016. The primary outcome was the likely to have SSIs after surgery than their counter- bmjgh- 2020- 003429).
    [Show full text]
  • Your Business Our Priority
    ANNUAL REPORT 2014 YOUR BUSINESS OUR PRIORITY www.pemudah.gov.my ANNUAL REPORT 2014 BREAKTHROUGH IDEAS THROUGH PUBLIC-PRIVATE SECTOR COLLABORATION ISSN 2289-7275 Published by PEMUDAH in collaboration with Malaysia Productivity Corporation (MPC) CONTENTS 04 Message from the Honourable CHAPTER 1 Prime Minister ENHANCING BUSINESS GROWTH 06 Foreword from the PEMUDAH 18 Snapshot of Initiatives Chairman 28 Completed Efficiency Improvements 08 Foreword from the PEMUDAH Co-Chair u Trading Across Borders 10 Vision and Values u Enforcing Contracts 11 About PEMUDAH u Dealing with Construction Permits 12 Members of PEMUDAH u Kuala Lumpur City Hall (DBKL) 14 Structure of PEMUDAH u Abandoned Housing 15 Collaboration Driven by Equality u Implementation of e-Payment Facilities u Safety and Security u Private Sector Efficiency and Accountability Towards Consumerism u Business Process Re-Engineering in Business Licensing u Halal Certification Management Focus Group u Public Relations 40 Completed Policy Improvements CHAPTER 2 u Paying Taxes PROPELLING THE CHANGE u Abandoned Housing Projects 52 Good Regulatory Practice (GRP) u Implementation of e-Payment 52 PEMUDAH at State Level Facilities 53 PEMUDAH Challenge 42 On-Going Efficiency Initiatives u Trading Across Borders 56 PEMUDAH Portal u Enforcing Contracts 58 Engagement with International Experts u Getting Credit u Safety and Security 59 Outreach Programmes u Getting Electricity 59 International Competitiveness u Business Process Re-Engineering in 67 The Way Forward Business Licensing u Registering Property
    [Show full text]
  • Evolution of Public Healthcare Facilities Designs to Health Trend in Malaysia a Retrospect of Nation Building from Pre-Colonial to Today
    8th World Congress on Design and Health 2012, 27th June-1st July 2012. Kuala Lumpur Convention Centre, Kuala Lumpur, Malaysia Pre-Congress Seminar 27th June 2012 EVOLUTION OF PUBLIC HEALTHCARE FACILITIES DESIGNS TO HEALTH TREND IN MALAYSIA A RETROSPECT OF NATION BUILDING FROM PRE-COLONIAL TO TODAY ASSOC. PROF. AR. DATIN NORWINA MOHD NAWAWI , INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA ABSTRACT Malaysia has its own inbuilt history of evolution of healthcare facilities designs from the traditional to contemporary mega structures we witness today. Each designs has its own story foretold the epidemiology phenomena, capacity and inspiration of a developing nation. From simplistic idea of housing aspects of health in single isolated buildings to complex structures that needs reviewing towards a sustainable future. The pictorial presentations briefly explore Malaysian public healthcare facilities from its humble beginnings in nation building from pre-colonial to what it is today. The objective is to provide ideas on the basis of why and how these designs were pragmatically evolved through time, to professionals, allied disciplines and users. Both qualitative and quantitative methodologies were adopted for this continuing research. Primary and secondary data, through literature review, observations, random interviews, post occupancy evaluations and hands-on experiences, were utilised. The significance of this presentation includes a sense of importance to the role of individual players in the healthcare services, construction industry, the trust that our Creator, and humanity had conferred on us, towards contributing and sustaining a healthy and hence a ‘wealthy” nation. EVOLUTION OF PUBLIC HEALTHCARE FACILITIES DESIGNS TO HEALTH TREND IN MALAYSIA - NMN 2 THE OUTLINE Introduction Malaysia - the country, Health System and Health Status –pre colonial, colonial and post independence Evolution of Public Healthcare Facilities Designs to health trend in nation building .
    [Show full text]
  • MISK-Booklet-2005 Chinese.Pdf
    Dr Zulkifli Ismail 4 Tight 65 5 6 7 8 9 10 11 12 13 14 15 16 17 18 / JOHOR Sultanah Aminah Hospital 07-223 1666 Muar Hospital 06-952 1901 Police & Ambulance 999 Batu Pahat Hospital 07-434 1999 Fire Department 994 Segamat Hospital 07-943 3333 From mobile phone to any Emergency numbers 112 Kluang Hospital 07-772 3333 National Poison Centre 04-6570 099 St. John’s Ambulance PAHANG – KL City 03-9200 4755 Tengku Ampuan Afzan Hospital 09-513 3333 – Klang Valley 03-3371 5005 Pekan Hospital 09-422 3333 TERENGGANU / Kuala Terengganu Hospital 09-623 3333 Dungun Hospital 09-844 3333 Besut Hospital 09-697 1200 WILAYAH PERSEKUTUAN Kuala Lumpur Hospital 03-2692 1044 KELANTAN Putrajaya Hospital 03-8888 0080 Kota Baharu Hospital 09-748 5533 Pasir Mas Hospital 09-790 9333 SELANGOR Tengku Ampuan Rahimah Hospital 03-3372 3333 Kajang Hospital 03-8736 3333 / Banting Hospital 03-3187 1333 Sungai Buloh Hospital 03-6156 1321 JOHOR Sabak Bernam Hospital 03-3216 3333 Johor Specialist Hospital 07-223 7811 Puteri Spec. Hospital 07-223 3377 PERLIS Century Med. Centre (J) 07-331 1722 Kangar Hospital 04-976 3333 Southern Hospital 07-431 7333 Pelangi Medical Centre 07-333 1263 KEDAH Hospital Penawar 07-252 1800 Alor Setar Hospital 04-730 3333 Medical Specialist Centre (JB) 07-224 3888 Sungai Petani Hospital 04-421 3333 Pusat Pakar Kluang Utama 07-771 8999 Kulim Hospital 04-490 3333 Langkawi Hospital KEDAH 04-966 3039 Klinik Mata & Pembedahan PULAU PINANG Sandhu 04-421 5089 Pulau Pinang Hospital 04-229 3333 Kedah Medical Centre 04-730 8878 Seberang Jaya Hospital 04-398
    [Show full text]
  • A Complication Prevented by the Primary Aetiology: a Case Report of LA Thrombus in an RVD Patient with Mitral Stenosis
    MedDocs Publishers ISSN: 2639-9237 Journal of Case Reports and Medical Images Open Access | Case Report A complication prevented by the primary aetiology: A case report of LA thrombus in an RVD patient with mitral stenosis Huzairi Sani1*; Nada Syazana2; Vijayendran R3; Amirul Asyraf3; Sazzli Kasim1,4 1Department of Cardiology, Universiti Teknologi MARA, Sungai Buloh, Malaysia 2Department of Pathology, Pulau Pinang General Hospital, Ministry of Health, Malaysia 3Department of Internal Medicine, Sungai Buloh Hospital, Selangor, Malaysia 4Institute for Pathology, Forensic Research Medicine (i-PPerform), Malaysia *Corresponding Author(s): Huzairi Sani Abstract Faculty of Medicine, Universiti Teknologi MARA, The aim of this paper was to present a case report in Sungai Buloh, Selangor 47000, Malaysia which prothombic or hypercoagulable states had caused a Email: [email protected] large mobilizing thrombus to developed in the Left Atrium (LA). This is perhaps due to delay in primary management. If it is not due to narrowing of the mitral valve as a result from mitral stenosis, the LA thrombus could have cause a Received: Mar 19, 2020 catastrophic complications. Accepted: Apr 30, 2020 Published Online: May 06, 2020 Journal: Journal of Case Reports and Medical Images Publisher: MedDocs Publishers LLC Online edition: http://meddocsonline.org/ Copyright: © Sani H (2020). This Article is distributed under the terms of Creative Commons Attribution 4.0 International License Introduction Case report Rheumatic Heart Disease (RHD) is the most common cause A 43-year-old gentleman with MS who was planned for Mi- of Mitral Stenosis (MS) and remains a cardiovascular health tral Valve (MV) replacement defaulted follow-up in 2017 after problem in developing countries [1,2].
    [Show full text]